🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

James A. Proudfoot

Veracyte (United States)

ORCID: 0009-0008-7063-5761
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.250Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study

JCO Precision Oncology(2024)10.1200/po.24.00161
Top 60%
0.250DataRank
Top 60%2 citations

Kritika Subramanian, Nimrod Barashi Gozal, Andres Ricaurte‐Fajardo, Eric V. Li, James A. Proudfoot +20 more

Papers

Driven by 10 papers — median percentile 40. Top paper: “Use of the Decipher genomic classifier among men with prostate cancer in the United States”.

Use of the Decipher genomic classifier among men with prostate cancer in the United States

JNCI Cancer Spectrum(2023)10.1093/jncics/pkad052
N/A
0.664DataRank · unranked
19 citations

James A. Proudfoot, Angela Y. Jia, Raed Zuhour, Randy Vince, Yang Liu +29 more

Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers

Cell(2025)10.1016/j.cell.2025.07.042
N/A
0.494DataRank · unranked
26 citations

Peter Dutey‐Magni, Marina Parry, Larissa Mendes, Ashwin Sachdeva, James A. Proudfoot +42 more

Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study

JCO Precision Oncology(2024)10.1200/po.24.00161
Top 60%
0.250DataRank
Top 60%2 citations

Kritika Subramanian, Nimrod Barashi Gozal, Andres Ricaurte‐Fajardo, Eric V. Li, James A. Proudfoot +20 more

Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial

European Urology Oncology(2025)10.1016/j.euo.2025.04.009
N/A
0.214DataRank · unranked
3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Jeffry Simko +17 more

Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-2186
N/A
0.165DataRank · unranked
2 citations

Uma Shankavaram, Shana Y. Trostel, Hong Zhang, Sumeyra Kartal, Houssein Abdul Sater +25 more

Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer

Prostate Cancer and Prostatic Diseases(2025)10.1038/s41391-025-01062-8
N/A
0.104DataRank · unranked
1 citations

Ralph Jiang, James A. Proudfoot, Elizabeth C. Chase, Krithika Suresh, Elai Davicioni +22 more

Genomic Predictors of Response to Metastasis-directed Therapy With or Without Androgen Deprivation Therapy

European Urology Oncology(2025)10.1016/j.euo.2025.07.007
N/A
0DataRank · unranked
0 citations

Kim Van der Eecken, Yang Song, Amol C. Shetty, Elai Davicioni, James A. Proudfoot +28 more

Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials

European Urology Oncology(2024)10.1016/j.euo.2024.10.017
N/A
0DataRank · unranked
2 citations

Paul L. Nguyen, James A. Proudfoot, Yang Liu, Alan Dal Pra, Daniel E. Spratt +16 more

Basal-luminal subtyping of localized high-risk prostate cancer and benefit of adding docetaxel to definitive radiotherapy with androgen suppression in the NRG Oncology/RTOG 0521 phase III trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5094
N/A
0DataRank · unranked
3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Felix Y. Feng +15 more

Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer

European Urology(2024)10.1016/j.eururo.2024.09.005
N/A
0DataRank · unranked
14 citations

Raag Agrawal, Nicholas K. Wang, Ida Sonni, Eric V. Li, Jaron Arbet +22 more